佰金生命科学(01466.HK)拟折价14.29%向三名投资者配售4000万股 净筹约1910万港元用作集团营运资金

Core Viewpoint - Baijin Life Sciences (01466.HK) announced a subscription agreement to issue a total of 40 million shares at a subscription price of HKD 0.48 per share, representing approximately 4.92% of the company's enlarged share capital, with the subscription price reflecting a discount of about 14.29% from the closing price on September 29 [1] Financial Summary - The total amount raised from the subscription is approximately HKD 19.2 million, with the estimated net proceeds being around HKD 19.1 million [1] - The net proceeds from the subscription will be used for the company's general working capital [1]